tiprankstipranks
Madrigal (MDGL)
NASDAQ:MDGL
US Market
MDGL
Madrigal Pharmaceuticals
RESEARCH TOOLSreports
Want to see MDGL full AI Analyst Report?

Madrigal Pharmaceuticals (MDGL) Ratios

1,343 Followers

Madrigal Pharmaceuticals Ratios

MDGL's free cash flow for Q1 2026 was $0.91. For the 2026 fiscal year, MDGL's free cash flow was decreased by $ and operating cash flow was $-0.30. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 3.50 4.01 6.10 5.38 3.12
Quick Ratio
 3.16 3.77 5.90 5.38 3.12
Cash Ratio
 0.69 0.64 0.59 0.84 2.86
Solvency Ratio
 -0.45 -0.44 -1.61 -1.59 -1.79
Operating Cash Flow Ratio
 -0.79 -0.61 -2.69 -2.74 -1.94
Short-Term Operating Cash Flow Coverage
 -157.98 -186.20 0.00 0.00 0.00
Net Current Asset Value
$ 498.43M$ 588.87M$ 745.06M$ 402.07M$ 196.19M
Leverage Ratios
Debt-to-Assets Ratio
 0.28 0.28 0.11 0.18 0.14
Debt-to-Equity Ratio
 0.64 0.59 0.16 0.29 0.25
Debt-to-Capital Ratio
 0.39 0.37 0.14 0.22 0.20
Long-Term Debt-to-Capital Ratio
 0.39 0.37 0.13 0.22 0.20
Financial Leverage Ratio
 2.26 2.09 1.38 1.58 1.84
Debt Service Coverage Ratio
 -10.08 -11.34 -30.68 -28.35 -73.39
Interest Coverage Ratio
 -11.68 -13.45 -33.94 -29.93 -74.06
Debt to Market Cap
 0.03 0.03 0.02 0.03 <0.01
Interest Debt Per Share
 12.89 16.79 6.31 6.95 3.14
Net Debt to EBITDA
 -0.40 -0.59 -0.04 -0.05 0.97
Profitability Margins
Gross Profit Margin
93.07%94.14%96.54%0.00%0.00%
EBIT Margin
-25.50%-27.75%-250.49%0.00%0.00%
EBITDA Margin
-25.40%-27.59%-249.88%0.00%0.00%
Operating Profit Margin
-27.68%-31.31%-276.39%0.00%0.00%
Pretax Profit Margin
-27.32%-30.08%-258.64%0.00%0.00%
Net Profit Margin
-27.32%-30.08%-258.64%0.00%0.00%
Continuous Operations Profit Margin
-27.32%-30.08%-258.64%0.00%0.00%
Net Income Per EBT
100.00%100.00%100.00%100.00%100.00%
EBT Per EBIT
98.70%96.06%93.58%98.20%100.61%
Return on Assets (ROA)
-25.21%-22.89%-44.70%-58.33%-81.46%
Return on Equity (ROE)
-50.15%-47.83%-61.76%-92.18%-149.63%
Return on Capital Employed (ROCE)
-35.26%-31.61%-57.03%-72.89%-119.01%
Return on Invested Capital (ROIC)
-35.20%-31.58%-56.97%-72.82%-118.72%
Return on Tangible Assets
-25.36%-23.02%-44.90%-58.33%-81.46%
Earnings Yield
-2.04%-2.21%-7.10%-8.64%-5.94%
Efficiency Ratios
Receivables Turnover
 6.04 7.13 3.35 0.00 0.00
Payables Turnover
 1.29 1.15 0.14 0.00 0.00
Inventory Turnover
 0.70 0.75 0.18 0.00 0.00
Fixed Asset Turnover
 79.54 148.87 39.24 0.00 0.00
Asset Turnover
 0.92 0.76 0.17 0.00 0.00
Working Capital Turnover Ratio
 1.27 1.07 0.26 0.00 0.00
Cash Conversion Cycle
 298.82 219.99 -449.07 0.00 0.00
Days of Sales Outstanding
 60.38 51.21 109.06 0.00 0.00
Days of Inventory Outstanding
 521.21 486.52 1.99K 0.00 0.00
Days of Payables Outstanding
 282.77 317.74 2.55K 0.00 0.00
Operating Cycle
 581.59 537.73 2.10K 0.00 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
 -9.23 -8.45 -21.42 -17.35 -13.12
Free Cash Flow Per Share
 -9.38 -8.47 -21.48 -17.43 -13.13
CapEx Per Share
 0.15 0.02 0.07 0.08 0.01
Free Cash Flow to Operating Cash Flow
 1.02 1.00 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
 -62.12 -405.90 -311.61 -219.22 -1.04K
Capital Expenditure Coverage Ratio
 -62.12 -405.90 -311.61 -219.22 -1.04K
Operating Cash Flow Coverage Ratio
 -0.77 -0.53 -3.81 -2.77 -4.51
Operating Cash Flow to Sales Ratio
 -0.24 -0.20 -2.53 0.00 0.00
Free Cash Flow Yield
-2.26%-1.45%-6.96%-7.53%-4.52%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -49.00 -45.32 -14.09 -11.57 -16.84
Price-to-Sales (P/S) Ratio
 10.63 13.63 36.44 0.00 0.00
Price-to-Book (P/B) Ratio
 27.90 21.68 8.70 10.67 25.20
Price-to-Free Cash Flow (P/FCF) Ratio
 -44.20 -68.75 -14.36 -13.28 -22.10
Price-to-Operating Cash Flow Ratio
 -56.55 -68.92 -14.41 -13.34 -22.12
Price-to-Earnings Growth (PEG) Ratio
 -1.67 1.10 -1.47 -0.72 -0.95
Price-to-Fair Value
 27.90 21.68 8.70 10.67 25.20
Enterprise Value Multiple
 -42.26 -49.99 -14.63 -12.05 -16.13
Enterprise Value
 12.16B 13.22B 6.58B 4.34B 4.69B
EV to EBITDA
 -42.26 -49.99 -14.63 -12.05 -16.13
EV to Sales
 10.73 13.79 36.55 0.00 0.00
EV to Free Cash Flow
 -44.62 -69.57 -14.41 -13.33 -20.85
EV to Operating Cash Flow
 -45.34 -69.74 -14.45 -13.39 -20.87
Tangible Book Value Per Share
 18.47 26.54 35.24 21.69 11.52
Shareholders’ Equity Per Share
 18.72 26.86 35.46 21.69 11.52
Tax and Other Ratios
Effective Tax Rate
 0.00 0.00 0.00 0.00 0.00
Revenue Per Share
 39.01 42.72 8.47 0.00 0.00
Net Income Per Share
 -10.66 -12.85 -21.90 -19.99 -17.23
Tax Burden
 1.00 1.00 1.00 1.00 1.00
Interest Burden
 1.07 1.08 1.03 1.04 1.01
Research & Development to Revenue
 0.40 0.41 1.31 0.00 0.00
SG&A to Revenue
 0.81 0.85 2.42 0.00 0.00
Stock-Based Compensation to Revenue
 0.08 0.10 0.44 0.00 0.00
Income Quality
 0.87 0.66 0.98 0.87 0.76
Currency in USD